Related Experiment Video
Updated: May 25, 2026
Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
Published on: April 25, 2025
Studying a complex tumor: potential and pitfalls
Siyuan Zheng1, Milan G Chheda, Roel G W Verhaak
1Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
Glioblastoma multiforme is a histopathologically heterogeneous disease with few treatment options. Therapy based on genomic alterations is rapidly gaining popularity because of the high response rate and high specificity. DNA copy number and exon-sequencing studies of glioblastoma multiforme samples have revealed recurrent genomic alterations in genes such as TP53, EGFR, and IDH1, but to date, this has not resulted in novel glioblastoma multiforme therapies. Identification of expression subtypes has resulted in new insights such as the association between genomic abnormalities and expression signatures. This review describes the types of genomic studies that have been performed and that are underway, the most prominent results, and the implications of genomic research for the development of clinical treatment modalities.
Insights
Genomic studies reveal glioblastoma multiforme alterations in genes like TP53 and EGFR. Despite insights, translating these genomic findings into novel glioblastoma multiforme therapies remains a challenge.
Area of Science:
- Neuro-oncology
- Genomics
- Molecular Biology
Background:
- Glioblastoma multiforme is a complex brain tumor with limited treatment options.
- Genomic-based therapies show promise due to high specificity and response rates.
Purpose of the Study:
- To review genomic studies in glioblastoma multiforme.
- To discuss the implications of genomic research for developing new treatments.
Main Methods:
- Analysis of DNA copy number and exon-sequencing data.
- Identification of gene expression subtypes and their association with genomic abnormalities.
Main Results:
- Recurrent genomic alterations identified in genes including TP53, EGFR, and IDH1.
- Expression subtypes offer new insights into glioblastoma multiforme biology.
Conclusions:
- Genomic research has advanced understanding of glioblastoma multiforme.
- Translating genomic discoveries into effective clinical therapies is ongoing.
